Biotech · Private company · Redwood City, CA, US

Soleno Therapeutics Inc

SEC CIK 0001484565

Track this companyFree. Adds Soleno Therapeutics Inc to your Dealase workspace and tells you when its record changes.

Clinical trials51 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline3

Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeENROLLING_BY_INVITATION · started Nov 26, 2025ClinicalTrials.gov NCT07450664 · fetched Nov 12, 2026
Open-Label Extension Study of DCCR in Patients With Prader-Willi SyndromePHASE3 · COMPLETED · started Jan 31, 2023ClinicalTrials.gov NCT05701774 · fetched Nov 12, 2026
PWS Outcomes Assessment StudyCOMPLETED · started Jul 15, 2019ClinicalTrials.gov NCT04102839 · fetched Nov 12, 2026
Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal PeriodPHASE3 · COMPLETED · started Oct 1, 2018ClinicalTrials.gov NCT03714373 · fetched Nov 12, 2026
A Study of Diazoxide Choline in Patients With Prader-Willi SyndromePHASE3 · COMPLETED · started May 9, 2018ClinicalTrials.gov NCT03440814 · fetched Nov 12, 2026